6.13.19
4 min. Read

Express Scripts talks but CVS launches. India’s 4,800 health startups.

In this article:

This is the sixth edition of the E&O weekly newsletter for paying subscribers. Topics include CVS’ new quasi-formulary for digital health, Cleveland Clinic’s Propeller Health study, India’s 4,000+ health startups and more.

Issue 006. Express Scripts talks but CVS launches. India's 4,800 health startups.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 77 percent open rate. Here's what's happening this week:

  • Your editor is in Helsinki courtesy of the Finnish government, which flew in a small contingent of healthcare reporters from the UK, Latvia, Japan, Germany, and the US to talk digital health in Santa's homeland. More on Finland-based digital therapeutics, heavy metal bands, and "sisu" (Finnish grit) in the weeks to come.
  • Boston Consulting Group put together a brief overview of how digital technologies are beginning to change the six stages of clinical trials, including study design and protocol development, site selection and initiation, patient recruitment and enrollment, trial monitoring, and more.
  • A massive survey from Phillips

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Help me get ahead. $200/year

Prescription Digital Therapeutics

All Newsletters
    215 articles
  • First
  • Previous
    • 1 of 22
  • Next
  • Last
Is it enough? Early MAC pricing for new digital mental health treatment code
4.18.25
6 min. Read
Scoop: Whoop’s first FDA clearance (and what will likely be its second)
4.10.25
7 min. Read
NightWare revenue. Oui terminates trial. 2025 FDA guidance priorities, posteriorities
1.17.25
7 min. Read
NY Medicaid won’t pay for Freespira, CanvasDx. Insolvent Mahana’s first asset sale.
12.13.24
9 min. Read
Final Fee Schedule: How CMS tweaked its digital mental health treatment G-codes
11.01.24
5 min. Read
CMS prices MedRhythms InTandem. Big Health courts health systems
10.11.24
4 min. Read
Mahana Therapeutics’ insolvency. FDA clears Happy Ring (Tinder founder’s smart ring)
10.04.24
6 min. Read
Flashback: How Proteus Digital Health’s outcomes-based pricing worked for Tennessee Medicaid
9.20.24
5 min. Read
Are the Digital Mental Health Treatment G Codes necessary? Or RTM dupes?
7.12.24
7 min. Read
Which PDTs are still around? New bill in Congress.
6.28.24
10 min. Read
  • First
  • Previous
    • 1 of 22
  • Next
  • Last